Good practices to optimise the performance of maternal and neonatal quality improvement teams: Results from a longitudinal qualitative evaluation in South Africa, before, and during COVID-19

PLoS One. 2024 Nov 19;19(11):e0314024. doi: 10.1371/journal.pone.0314024. eCollection 2024.

Abstract

Many maternal and neonatal deaths can be avoided if quality healthcare is provided. To this end, the South African National Department of Health implemented a quality improvement (QI) programme (2018-2022) to improve maternal and neonatal health services in 21 public health facilities. This study sought to identify good practices aimed at improving QI teams' performance by identifying optimal facility-level contextual factors and implementation processes. We purposively selected 14 facilities of the 21 facilities for a longitudinal qualitative process evaluation. We interviewed 17 team leaders, 47 members, and five QI advisors who provided technical support to the teams. The data were analysed using framework analysis. We choose the Consolidated Framework for Implementation Research as framework given that it explicates contexts and processes that shape programme implementation. Six quality improvement teams were assessed as well-performing, and eight as less well-performing. This research conceptualises a 'life course lens' for setting up and managing a QI team. We identified eight good practices, six related to implementation processes, and two contextual variables that will optimise team performance. The two most impactful practices to improve the performance of a QI team were (i) selecting healthcare workers with quality improvement-specific characteristics, and (ii) appointing advisors whose interpersonal skills match their technical quality improvement competencies.

MeSH terms

  • COVID-19* / epidemiology
  • Female
  • Humans
  • Infant, Newborn
  • Longitudinal Studies
  • Maternal Health Services / organization & administration
  • Maternal Health Services / standards
  • Pregnancy
  • Qualitative Research
  • Quality Improvement*
  • SARS-CoV-2
  • South Africa / epidemiology

Grants and funding

The evaluation was funded by ELMA Philanthropies (20-P0001-C), an anonymous donor, and the South African Medical Research Council. The funders did not play a role in designing the study, data collection and analysis, our decision to publish, and drafting the manuscript.